To Evaluate the Safety and Efficacy of NVP-2203 Tablet in Patients

NCT05856487 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Diseases

Interventions

DRUG: NVP-2203
DRUG: NVP-2203-R1
DRUG: NVP-2203-R2
DRUG: NVP-2203-R3
DRUG: NVP-2203 Placebo
DRUG: NVP-2203-R1 Placebo
DRUG: NVP-2203-R2 Placebo
DRUG: NVP-2203-R3 Placebo

Sponsor

NVP Healthcare